Accepted by Scopus and Clarivate Analytics to be indexed in Science Citation Index Expanded, JCR, Current Contents and Biological Abstracts

Editorial 6.1

Author List
Sabine Kinloch

Abstract

A very Happy New Year! The Journal is now in its 6th year of publication and is celebrating the progress achieved in treatment and eradication research of viral infections.

The Journal is honoured to welcome Dr Christina Psomas, MD, PhD, from the European Hospital in Marseille as an editor. She is an active contributor to the Journal and has been, in particular, coordinating important reports from major international meetings. In this issue we publish articles from the US, UK, Australia, the Middle East and Asia, focusing on HIV and hepatitis B.

The article by Gawri Rajakaruna et al. reports a case of chorea associated with low-level HIV-1 viremia and how intensification with a combination including novel antiretroviral drugs was able to control symptoms.

Michelle Chintanaphol et al. describe in Thai patients the feasibility and safety of colon biopsies for research purposes during acute HIV-1 infection and follow-up visits and conclude that there were only infrequent and mild complications of sigmoidoscopy in this population. Majed Nusair et al. reviewed the HBV care pathway in Jordan, which shows a significant improvement in terms of decreased prevalence with, however, gaps in screening and linkage to care.

Srishti Chhabra et al. highlight in their retrospective study on malignancy and allcause mortality in adolescents and young adults living with perinatally acquired HIV an increased risk of malignancy, mostly driven by lymphoma and of all-cause mortality as compared to HIV-1 negative peers. In an impressive piece of work, Boettiger et al. review the integrated atherosclerotic cardio-vascular disease care in HIV urban centres in Asia and availability of clinical screening, diagnostic testing, procedures and treatment. Michael Peluso et al. provide an important document regarding risk mitigation during HIV-1 analytic treatment interruption in cure research. The same author and colleagues contribute with another article to research into the CD30 in plasma and CSF in various types of patient cohorts. Finally, Christina Psomas has compiled the highlights of the 17th EACS Conference, held November 2019 in Basel, Switzerland, which had an emphasis on prevention and follow-up of cohorts using novel antiretroviral agents.

A very Happy New Year! The Journal is now in its 6th year of publication and is celebrating the progress achieved in treatment and eradication research of viral infections.

The Journal is honoured to welcome Dr Christina Psomas, MD, PhD, from the European Hospital in Marseille as an editor. She is an active contributor to the Journal and has been, in particular, coordinating important reports from major international meetings. In this issue we publish articles from the US, UK, Australia, the Middle East and Asia, focusing on HIV and hepatitis B.

The article by Gawri Rajakaruna et al. reports a case of chorea associated with low-level HIV-1 viremia and how intensification with a combination including novel antiretroviral drugs was able to control symptoms.

Michelle Chintanaphol et al. describe in Thai patients the feasibility and safety of colon biopsies for research purposes during acute HIV-1 infection and follow-up visits and conclude that there were only infrequent and mild complications of sigmoidoscopy in this population. Majed Nusair et al. reviewed the HBV care pathway in Jordan, which shows a significant improvement in terms of decreased prevalence with, however, gaps in screening and linkage to care.

Srishti Chhabra et al. highlight in their retrospective study on malignancy and allcause mortality in adolescents and young adults living with perinatally acquired HIV an increased risk of malignancy, mostly driven by lymphoma and of all-cause mortality as compared to HIV-1 negative peers. In an impressive piece of work, Boettiger et al. review the integrated atherosclerotic cardio-vascular disease care in HIV urban centres in Asia and availability of clinical screening, diagnostic testing, procedures and treatment. Michael Peluso et al. provide an important document regarding risk mitigation during HIV-1 analytic treatment interruption in cure research. The same author and colleagues contribute with another article to research into the CD30 in plasma and CSF in various types of patient cohorts. Finally, Christina Psomas has compiled the highlights of the 17th EACS Conference, held November 2019 in Basel, Switzerland, which had an emphasis on prevention and follow-up of cohorts using novel antiretroviral agents.

Article Category

HIV Treatment

Article Type

Editorial

Posted Date

20-02-2020

File Name
1582226001jve_v6_i1_Editorial rev.pdf

Editorial 6.1

Tables & Figures

Back to top